ImportRefusal LogoImportRefusal

Dannex Ltd

⚠️ High Risk

FEI: 3011640723 • Accra • GHANA

FEI

FEI Number

3011640723

📍

Location

Accra

🇬🇭

Country

GHANA
🏢

Address

North Industrial Area, 5 Dadeban Rd. Ring Road North, Accra, , Ghana

High Risk

FDA Import Risk Assessment

62.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

15
Total Refusals
10
Unique Violations
1/7/2026
Latest Refusal
2/16/2010
Earliest Refusal

Score Breakdown

Violation Severity
71.5×40%
Refusal Volume
44.6×30%
Recency
97.1×20%
Frequency
9.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7514×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

22802×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

2601×

FALSE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4881×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

Refusal History

DateProductViolationsDivision
1/7/2026
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
1/2/2026
54YEL99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
10/21/2024
54YGT99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
5/28/2024
54AGL99VITAMIN, N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/29/2022
66YBL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
11/12/2021
66YCL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
8/19/2021
54YYL99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
9/4/2020
66YBL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
2280DIRSEXMPT
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/6/2020
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
11/1/2018
66BBN99STIMULANT N.E.C.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
336INCONSPICU
75UNAPPROVED
Division of Northeast Imports (DNEI)
7/2/2018
55PP25BENZOIC ACID (PHARMACEUTIC NECESSITY - ANTIFUNGAL AGENT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/8/2017
66YBL99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
2280DIRSEXMPT
75UNAPPROVED
Division of Northeast Imports (DNEI)
9/6/2017
54ACL07NICOTINAMIDE (NIACINAMIDE) (VITAMIN)
2300DIETARYLBL
260FALSE
473LABELING
488HEALTH C
Division of Northeast Imports (DNEI)
6/7/2011
66VCS99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
2/16/2010
54AGL99VITAMIN, N.E.C.
118NOT LISTED
75UNAPPROVED
New England District Office (NWE-DO)

Frequently Asked Questions

What is Dannex Ltd's FDA import refusal history?

Dannex Ltd (FEI: 3011640723) has 15 FDA import refusal record(s) in our database, spanning from 2/16/2010 to 1/7/2026.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Dannex Ltd's FEI number is 3011640723.

What types of violations has Dannex Ltd received?

Dannex Ltd has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Dannex Ltd come from?

All FDA import refusal data for Dannex Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.